LabOS

Status: assess | Maturity: emerging | Last reviewed: 2026-03-20

What it does

LabOS is a platform from Artificial designed to orchestrate self-driving / autonomous laboratory workflows. It combines electronic lab notebook (ELN) functionality, laboratory information management (LIMS), and AI-driven experiment scheduling and optimisation into a unified operating system for automated research laboratories.

LabOS is designed for labs running robotic liquid handlers, automated screening systems, and connected analytical instruments. It enables closed-loop experimentation: plan → execute → measure → AI suggests next experiment → execute.

Key capabilities

  • Integrated ELN and LIMS for structured data capture
  • AI-driven experiment design and closed-loop optimisation
  • Orchestration of laboratory automation hardware (liquid handlers, robots)
  • Protocol management and audit trail
  • Integration with analytical instruments for automated data ingestion
  • SSO/SAML support for institutional deployment

Fit for Sheffield researchers

Relevant to research groups running automated or high-throughput experimental workflows — particularly in Chemistry, Materials Science, Biochemistry, and pharmaceutical research. The Royce Institute and other Sheffield research infrastructure with automated equipment would be natural test cases.

Deployment requires significant technical setup and vendor engagement. Not suitable for individual researchers or standard wet-lab use — aimed at infrastructure-level adoption.

Licensing and access

Enterprise subscription. No self-service sign-up — requires vendor engagement. Pricing not publicly disclosed; contact Artificial directly for HE/research institution pricing.

Trust and governance notes

Insufficient public information on data handling, GDPR compliance, or data residency. Any institutional evaluation must include a thorough Data Protection Impact Assessment (DPIA). Experiment data may be commercially sensitive — clarify data processing terms before deployment.

Observed limitations

  • High cost and complexity of deployment
  • Vendor lock-in risk for automated lab workflows once integrated
  • Primarily aimed at pharmaceutical and biotech sectors — HE/academic features may be limited
  • Limited independent user reviews at time of assessment
  • Requires hardware integration expertise

alphafold · chemcrow · ag2-autogen

Sources and evidence